Pharmacology for Advanced Practice Nurses
Study online at https://quizlet.com/_7vy4gj
1. Can a geriatric nurse practitioner take a position as a pediatric nurse practi-
tioner when she has years of pediatric experience as an RN: No. Experience as an RN is
not sufficient to be licensed as a nurse practitioner as the scope of practice of an NP is distinctly different from that of
an RN.
2. Must the collaborating physician co-sign the NP's orders and charts?: No. NPs do
not function under the supervision of physicians-they function in collaboration with physicians. Nurse practitioners are
independently responsible for the diagnosis and treatment of the patients they serve.
3. National Provider Identifier (NPI): All health care providers must apply for the NPI to use in all
electronic health care transactions.
4. DEA Number: Federal Drug Enforcement Administration Number is required to prescribe and dispense
narcotic and controlled substances.
5. What 3 requirements do NPs need to prescribe medications.: 1. NPI (National Provider
Identifier)-used in all electronic health care transactions.
2. DEA number (Federal Drug Enforcement Number) required to prescribe or dispense narcotic and controlled
substances.
3.New York State Official Prescription Forms
6. What is the knowledge required to be a safe prescriber?: 1. Pathophysiology and disease
process
2. Pharmacology
3. Rational drug selection
7. How can the NP improve drug adherence?: 1. prescribe longer-acting drugs
2. Use of reinforcements
3. Caregiver roles
4.Simplifying regimen
5. Cues as reminders
6. Follow-up visits.
8. Federal Food and Drug Act of 1906: Enacted due to children dying from tainted food products.
9. 1938 Amendment to the Federal Food and Drug Act: Made after more than 100 children
died after taking sulfanilamide
10. sulfanilamide: Sulfa drugs were used to treat infections before penicillin and other antibiotics were discov-
ered. Most sulfa drugs are antibiotics but some are prescribed for treating ulcerative colitis.
1/6
, Pharmacology for Advanced Practice Nurses
Study online at https://quizlet.com/_7vy4gj
11. 1962 Harris Kefauver Amendment: Mandated preclinical animal trials before testing drugs in
children.
12. Orphan Drug Act of 1983: Fosters drug development for rare diseases
13. Drug Price Competition and Patent Term Restoration Act of 1984: Expanded the
number of geriatric drugs suitable for an abbreviated new drug application (ANDA)
14. Pediatric Research Equity Act of 2003: required pediatric studies of safety and efficacy
15. Drug Quality & Safety Act, 2013: 1. Enhanced security provisions within the drug supply chain.
2. Increased ability to trace drug distribution and recall in the event of a harmful product.
16. U.S. Food and Drug Administration (FDA): -The agency in the U.S. federal government that has
the power to approve and disapprove new drugs.
-Official labeling
-Surveillance of adverse drug effects
-Methods of manufacture and distribution
-Medical devices
-Advertising of prescription drugs
17. New Drug Approval Process: 1. Preclinical research
2. Phase of drug testing before approval (Phase I, Phase II, Phase III)
3. New drug application
4. Post-marketing research
18. Expedited New Drug Approval: 1. Priority review
2. Breakthrough therapy
3. Accelerated approval
4. Fast track
19. Official Labeling: The FDA regulates what goes on a label. Labeling on OTC drugs and inserts in prescription
drugs.
20. Off-Labeling prescribing: Prescribing for use not indicated on the official FDA label.
21. Controlled Substance Laws: 1. Regulate the manufacture and dispensing of drugs identified as
"controlled" drugs.
2. US Drug Enforcement Administration (DEA) number-registration with the DEA
3. Manufacture, prescribing, dispensing
4. Record keeping
2/6
Study online at https://quizlet.com/_7vy4gj
1. Can a geriatric nurse practitioner take a position as a pediatric nurse practi-
tioner when she has years of pediatric experience as an RN: No. Experience as an RN is
not sufficient to be licensed as a nurse practitioner as the scope of practice of an NP is distinctly different from that of
an RN.
2. Must the collaborating physician co-sign the NP's orders and charts?: No. NPs do
not function under the supervision of physicians-they function in collaboration with physicians. Nurse practitioners are
independently responsible for the diagnosis and treatment of the patients they serve.
3. National Provider Identifier (NPI): All health care providers must apply for the NPI to use in all
electronic health care transactions.
4. DEA Number: Federal Drug Enforcement Administration Number is required to prescribe and dispense
narcotic and controlled substances.
5. What 3 requirements do NPs need to prescribe medications.: 1. NPI (National Provider
Identifier)-used in all electronic health care transactions.
2. DEA number (Federal Drug Enforcement Number) required to prescribe or dispense narcotic and controlled
substances.
3.New York State Official Prescription Forms
6. What is the knowledge required to be a safe prescriber?: 1. Pathophysiology and disease
process
2. Pharmacology
3. Rational drug selection
7. How can the NP improve drug adherence?: 1. prescribe longer-acting drugs
2. Use of reinforcements
3. Caregiver roles
4.Simplifying regimen
5. Cues as reminders
6. Follow-up visits.
8. Federal Food and Drug Act of 1906: Enacted due to children dying from tainted food products.
9. 1938 Amendment to the Federal Food and Drug Act: Made after more than 100 children
died after taking sulfanilamide
10. sulfanilamide: Sulfa drugs were used to treat infections before penicillin and other antibiotics were discov-
ered. Most sulfa drugs are antibiotics but some are prescribed for treating ulcerative colitis.
1/6
, Pharmacology for Advanced Practice Nurses
Study online at https://quizlet.com/_7vy4gj
11. 1962 Harris Kefauver Amendment: Mandated preclinical animal trials before testing drugs in
children.
12. Orphan Drug Act of 1983: Fosters drug development for rare diseases
13. Drug Price Competition and Patent Term Restoration Act of 1984: Expanded the
number of geriatric drugs suitable for an abbreviated new drug application (ANDA)
14. Pediatric Research Equity Act of 2003: required pediatric studies of safety and efficacy
15. Drug Quality & Safety Act, 2013: 1. Enhanced security provisions within the drug supply chain.
2. Increased ability to trace drug distribution and recall in the event of a harmful product.
16. U.S. Food and Drug Administration (FDA): -The agency in the U.S. federal government that has
the power to approve and disapprove new drugs.
-Official labeling
-Surveillance of adverse drug effects
-Methods of manufacture and distribution
-Medical devices
-Advertising of prescription drugs
17. New Drug Approval Process: 1. Preclinical research
2. Phase of drug testing before approval (Phase I, Phase II, Phase III)
3. New drug application
4. Post-marketing research
18. Expedited New Drug Approval: 1. Priority review
2. Breakthrough therapy
3. Accelerated approval
4. Fast track
19. Official Labeling: The FDA regulates what goes on a label. Labeling on OTC drugs and inserts in prescription
drugs.
20. Off-Labeling prescribing: Prescribing for use not indicated on the official FDA label.
21. Controlled Substance Laws: 1. Regulate the manufacture and dispensing of drugs identified as
"controlled" drugs.
2. US Drug Enforcement Administration (DEA) number-registration with the DEA
3. Manufacture, prescribing, dispensing
4. Record keeping
2/6
